Clinical Trials Browser

Phase EARLY_PHASE1 × Unknown × Lymphoma, Non-Hodgkin × Clear all

NCT06277011 2024-02-26

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Phase EARLY_PHASE1 Unknown

18 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04696705 2021-01-06

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Phase EARLY_PHASE1 Unknown

10 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT04638270 2020-11-20

Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL

Phase EARLY_PHASE1 Unknown

16 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT03790891 2020-03-13

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

12 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT04226989 2020-02-21

A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Phase EARLY_PHASE1 Unknown

72 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04169932 2019-11-20

The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma

Phase EARLY_PHASE1 Unknown

20 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT04028440 2019-09-26

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Phase EARLY_PHASE1 Unknown

6 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Peripheral

NCT03910842 2019-09-06

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Phase EARLY_PHASE1 Unknown

12 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin